Alterola Biotech, Inc.

ABTI · OTC
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Operating Activities
Net Income-$136-$719-$20-$535
Dep. & Amort.$0$4$0$0
Deferred Tax$0-$4-$47-$11
Stock-Based Comp.$0$180$0$0
Change in WC$14$128$195-$248
Other Non-Cash$0$335-$12$0
Operating Cash Flow-$122-$75$117-$793
Investing Activities
PP&E Inv.$0-$19$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0-$158$18
Investing Cash Flow$54-$19-$158$18
Financing Activities
Debt Repay.
Stock Issued$0$0$0$0
Stock Repurch.-$171-$44$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$178$113$119$796
Financing Cash Flow$7$68$119$796
Forex Effect$34$54-$118$13
Net Chg. in Cash-$27$28-$4-$2
Supplemental Information
Beg. Cash$37$9$13$15
End Cash$9$37$9$13
Free Cash Flow-$122-$94$117-$793